Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 75 | 0 | 18 | 87 | 0 |
| Gross Profit | 75 | N/A | 18 | 87 | 0 |
| Operating Expenses | 13,428 | 14,660 | 17,444 | 17,424 | 14,405 |
| Operating Income | -13,353 | -14,660 | -17,426 | -17,337 | -14,405 |
| Other Income | 86 | 7 | 4 | 5 | 5 |
| Pre-tax Income | -13,268 | -14,653 | -17,422 | -17,332 | -14,399 |
| Net Income Continuous | -13,268 | -14,653 | -17,422 | -17,332 | -14,399 |
| Net Income | $-13,268 | $-14,653 | $-17,422 | $-17,332 | $-14,399 |
| EPS Basic Total Ops | -25.00 | -28.00 | -33.00 | -34.00 | -28.00 |
| EPS Basic Continuous Ops | -25.32 | -28.00 | -33.57 | -33.61 | -27.94 |
| EPS Diluted Total Ops | -25.00 | -28.00 | -33.00 | -34.00 | -28.00 |
| EPS Diluted Continuous Ops | -25.32 | -28.00 | -33.57 | -33.61 | -27.94 |
| EBITDA(a) | $-13,298 | $-14,601 | $-17,364 | $-17,270 | $-14,337 |